Literature DB >> 10487852

Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin.

I Y Adamson1, J Bakowska.   

Abstract

Keratinocyte growth factor (KGF) and hepatocyte growth factor (HGF) are known mitogens for normal alveolar Type 2 cells in vitro and in vivo. We wished to determine whether these two growth factors are involved in lung repair after epithelial cell necrosis by determining the levels of each factor in lung lavage fluid collected serially after bleomycin-induced injury, and how these values relate specifically to proliferation of bronchiolar and alveolar epithelial cells. Rats received an intratracheal injection of 1 unit bleomycin in 0.5 ml water and were killed at intervals up to 4 weeks with 1 muCi/g tritiated thymidine injected 1 hour before death. Early necrosis of bronchiolar epithelial (BR) cells and Type 1 alveolar epithelium was followed by an increase in inflammatory cell numbers and high protein levels in bronchoalveolar lavage (BAL) fluids. In addition, the levels of KGF and HGF, measured by enzyme-linked immunosorbent assay in BAL, increased as early as 3 days and peaked at 7-14 days, when KGF was measured at 160 pg/ml (n = 50) and HGF reached 460 pg/ml (n = 40). Both values dropped sharply after 2 weeks. Epithelial cell proliferation was quantitated as percentage of labeled cells in autoradiographs of methacrylate sections. Labeling of BR cells predominated in the first week and peaked at 7% at 3 days. Type 2 cell proliferation was delayed somewhat but occurred in 3 to 10 days with a peak of 7% labeled cells at 1 week. The results demonstrate that both HGF and KGF are present in the lung in greatly increased amounts soon after bleomycin-induced epithelial cell necrosis. These high levels are associated with both BR and alveolar epithelial cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487852      PMCID: PMC1866877          DOI: 10.1016/S0002-9440(10)65194-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

2.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

Authors:  J S Rubin; A M Chan; D P Bottaro; W H Burgess; W G Taylor; A C Cech; D W Hirschfield; J Wong; T Miki; P W Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 3.  Pathobiology of pulmonary fibrosis.

Authors:  E Crouch
Journal:  Am J Physiol       Date:  1990-10

Review 4.  Messages and handshakes: cellular interactions in pulmonary fibrosis.

Authors:  R K Kumar; A W Lykke
Journal:  Pathology       Date:  1995-01       Impact factor: 5.306

5.  Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts.

Authors:  M Brauchle; K Angermeyer; G Hübner; S Werner
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

6.  Hepatocyte growth factor is a mitogen for alveolar type II cells in rat lavage fluid.

Authors:  R J Mason; K McCormick-Shannon; J S Rubin; T Nakamura; C C Leslie
Journal:  Am J Physiol       Date:  1996-07

7.  Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.

Authors:  R J Panos; J S Rubin; K G Csaky; S A Aaronson; R J Mason
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture.

Authors:  K Sugahara; J S Rubin; R J Mason; E L Aronsen; J M Shannon
Journal:  Am J Physiol       Date:  1995-09

9.  Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo.

Authors:  T R Ulich; E S Yi; K Longmuir; S Yin; R Biltz; C F Morris; R M Housley; G F Pierce
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 10.  Drug-induced pulmonary fibrosis.

Authors:  I Y Adamson
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

View more
  16 in total

Review 1.  The functions of cytokines and their uses in toxicology.

Authors:  J R Foster
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

2.  STAT3 accelerates uterine epithelial regeneration in a mouse model of decellularized uterine matrix transplantation.

Authors:  Takehiro Hiraoka; Yasushi Hirota; Tomoko Saito-Fujita; Mitsunori Matsuo; Mahiro Egashira; Leona Matsumoto; Hirofumi Haraguchi; Sudhansu K Dey; Katsuko S Furukawa; Tomoyuki Fujii; Yutaka Osuga
Journal:  JCI Insight       Date:  2016-06-02

3.  Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration.

Authors:  Onder Alpdogan; Vanessa M Hubbard; Odette M Smith; Neel Patel; Sydney Lu; Gabrielle L Goldberg; Daniel H Gray; Jared Feinman; Adam A Kochman; Jeffrey M Eng; David Suh; Stephanie J Muriglan; Richard L Boyd; Marcel R M van den Brink
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

4.  Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon.

Authors:  Ying Xia; Yu-Feng Xia; Qi Lv; Meng-Fan Yue; Si-Miao Qiao; Yan Yang; Zhi-Feng Wei; Yue Dai
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

Review 5.  Hepatocyte growth factor in lung repair and pulmonary fibrosis.

Authors:  Ronald Allan M Panganiban; Regina M Day
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

Review 6.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

7.  Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.

Authors:  Hiroto Matsuoka; Thomas H Sisson; Teruaki Nishiuma; Richard H Simon
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-13       Impact factor: 6.914

8.  Hepatocyte growth factor regulates angiotensin converting enzyme expression.

Authors:  Regina M Day; Gerald Thiel; Julie Lum; Rubén D Chévere; Yongzhen Yang; Joanne Stevens; Laura Sibert; Barry L Fanburg
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

9.  The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.

Authors:  Noboru Hattori; Shinya Mizuno; Yuka Yoshida; Kazuo Chin; Michiaki Mishima; Thomas H Sisson; Richard H Simon; Toshikazu Nakamura; Masayuki Miyake
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

10.  Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model.

Authors:  L Grier Arthur; Keith A Kuenzler; Marshall Z Schwartz
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.